中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
20期
93-94
,共2页
布地奈德混悬液雾化%吸入治疗%耳鼻喉科急性炎症%疗效
佈地奈德混懸液霧化%吸入治療%耳鼻喉科急性炎癥%療效
포지내덕혼현액무화%흡입치료%이비후과급성염증%료효
Budesonide%Inhalation treatment%Acute inflammation in department of ENT%Curative effect
目的:分析布地奈德混悬液雾化吸入治疗耳鼻喉科急性炎症疗效。方法选择我院2013年6月~2015年2月耳咽喉科收治的100例急性炎症患者为研究对象,均接受常规治疗,将其随机分组。常规组患者辅以常规雾化治疗,试验组患者辅以布地奈德混悬液雾化吸入治疗。对比分析两组患者疗效的差异。结果采用χ2检验分析进行数据统计,试验组患者疗效高于常规组,差异有统计学意义(P<0.05)。结论在耳咽喉科急性炎症患者中采用布地奈德混悬液雾化吸入治疗,有助于提高疗效,促进康复。
目的:分析佈地奈德混懸液霧化吸入治療耳鼻喉科急性炎癥療效。方法選擇我院2013年6月~2015年2月耳嚥喉科收治的100例急性炎癥患者為研究對象,均接受常規治療,將其隨機分組。常規組患者輔以常規霧化治療,試驗組患者輔以佈地奈德混懸液霧化吸入治療。對比分析兩組患者療效的差異。結果採用χ2檢驗分析進行數據統計,試驗組患者療效高于常規組,差異有統計學意義(P<0.05)。結論在耳嚥喉科急性炎癥患者中採用佈地奈德混懸液霧化吸入治療,有助于提高療效,促進康複。
목적:분석포지내덕혼현액무화흡입치료이비후과급성염증료효。방법선택아원2013년6월~2015년2월이인후과수치적100례급성염증환자위연구대상,균접수상규치료,장기수궤분조。상규조환자보이상규무화치료,시험조환자보이포지내덕혼현액무화흡입치료。대비분석량조환자료효적차이。결과채용χ2검험분석진행수거통계,시험조환자료효고우상규조,차이유통계학의의(P<0.05)。결론재이인후과급성염증환자중채용포지내덕혼현액무화흡입치료,유조우제고료효,촉진강복。
Objective To analyze the curative efect of budesonide inhalation in treatment of acute inflammation in the department of ENT.MethodsA total of 100 patients with acute inflammation were treated in our hospital from June 2013 to February 2015,they were treated with conventional therapy and were randomly divided into the treatment group,the reference group the patients were treated with conventional spray treatment,experimental group patients were treated with budesonide inhalation therapy,diferences in eficacy between the two groups.ResultsThe clinical eficacy of the test group was significantly higher than that of the reference group,the diference was statisticaly significant(P< 0.05).Conclusion In the ear pharyngeal throat acute inflammation patients using budesonide suspension liquid atomization inhalation treatment,help to improve the curative efect,promote the rehabilitation and is worthy to be popularized.